MitoRx Therapeutics Appoints Dr. Lubor Gaal as Chief Business Officer and Stacey Massey as Finance Director
Position
Finance Director
Company
MitoRx Therapeutics
OxfordBiotechnologyHealth CareTherapeuticsDescription
MitoRx Therapeutics announces the appointments of Dr. Lubor Gaal as Chief Business Officer (CBO) and Stacey Massey as Finance Director, reinforcing the company’s commitment to advancing its innovative programs including its obesity program offering weight loss with muscle protection and scaling its operations to address significant unmet medical needs.
Quick answer
MitoRx Therapeutics Appoints Dr. Lubor Gaal as Chief Business Officer and Stacey Massey as Finance Director (January 9, 2025). MitoRx Therapeutics is based in Oxford, England, United Kingdom.
- Who is the new Finance Director at MitoRx Therapeutics?
- MitoRx Therapeutics named Stacey Massey Finance Director, announced January 9, 2025.
- What did MitoRx Therapeutics announce on January 9, 2025?
- MitoRx Therapeutics announces the appointments of Dr. Lubor Gaal as Chief Business Officer (CBO) and Stacey Massey as Finance Director, reinforcing the company’s commitment to advancing its innovative programs including its obesity program offering weight loss with muscle protection and scaling its operations to address significant unmet medical needs.
- What does MitoRx Therapeutics do?
- MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction,...
- Where is MitoRx Therapeutics based?
- MitoRx Therapeutics is based in Oxford, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- Nimbus Therapeutics (January 9, 2025), GEMMABio (January 9, 2025), Noema Pharma (January 8, 2025) and Actio Biosciences (January 8, 2025) also announced leadership changes within 45 days of MitoRx Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Nimbus Therapeutics appoints Peter J. Tummino, Ph.D. as President of Research and Development (January 9, 2025)
- GEMMABio Appoints May Orfali, MD, MBA, as Chief Medical Officer (January 9, 2025)
- Noema Pharma Appoints Michael Samar as Chief Financial Officer and Volker Knappertz as Executive Vice President of Research and Development (January 8, 2025)
- Actio Biosciences Appoints Cayce Denton as Chief Financial Officer (January 8, 2025)
- Gain Therapeutics Appoints Gene Mack as President and Chief Executive Officer, Gianluca Fuggetta as Senior Vice President of Finance (January 10, 2025)
- Centessa Pharmaceuticals plc Appoints Stephen Kanes MD PhD as Chief Medical Officer (January 8, 2025)
Who to call at MitoRx Therapeutics, and when
A new leader at MitoRx Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day MitoRx Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MitoRx Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MitoRx Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MitoRx Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
MitoRx Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.